There are some risks associated with compounded tirzepatide (as well as similar drugs like compounded semaglutide), such as: Dosing errors resulting from incorrectly measuring the dose, which can lead to serious side effects from taking too much medicine (With Mounjaro, the dose is loaded into the prefilled pen, so it is unlikely you will inject an incorrect dose.) Ingredients, such as retatrutide, that are labeled for research purposes or not for human consumption and have been found in compounded products that are provided to patients Contaminated and non-sterile products, which can be dangerous Counterfeit drugs, that may contain the wrong drug, too much or too little of the drug, or no drug at allalong with illegal sales that do not require a prescription In addition to these risks, remember that compounded tirzepatide products have not been tested or FDA approved, so it is not known if the product you receive is safe, effective, and of high quality

It belongs to a class of drugs known as GLP-1 receptor agonists, which help regulate appetite and blood sugar levels
They can advise whether to discard or continue using it based on their specific formulation
An October 2023 JAMA research letter found gastroparesis risk three to four times higher and pancreatitis risk about nine times higher among GLP-1 users compared to people on Contrave (bupropion-naltrexone)
While occasional difficulty is totally normal, persistent problems are a red flag that something more serious could be happening and should not be ignored
The peak phase is often less intense but longer, lasting up to two weeks